Spotlighting Methods to Ensure Strategic Registry Development for PostLaunch Success for Rare Disease

Time: 3:00 pm
day: Day Two


  • Uncovering the role of real world evidence to support post-marketing activities including HTA submissions and expanding the regulatory label in rare diseases
  • Highlighting approaches to develop registries that cover the patient population and meet standards for HTA agencies
  • Exploring best practices for real world evidence generation to facilitate label expansion and support data-driven decision-making throughout the product’s lifecycle, ensuring its continued success in the market